Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC
Clinical trial NCT07244016 · RECRUITING
Trial details
- NCT number
- NCT07244016
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-20
- Primary completion
- 2026-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.